Alison Ritchie
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Ovarian cancer diagnosis and treatment 6
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Morwenna Muir (4 shared papers)Jeff Cummings (4 shared papers)Duncan Ian Jodrell (1 shared paper)Rhona E. Aird (1 shared paper)Peter John Sadler (1 shared paper)Simon P. Langdon (14 shared papers)William R. Miller (9 shared papers)John F. Smyth (10 shared papers)
- Journals
- European Journal of Cancer (4 papers)Biomaterials Science (3 papers)British Journal of Cancer (2 papers)Annals of Oncology (2 papers)Advanced Healthcare Materials (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Alison Ritchie
44 papers receiving 1.7k citations
Alison Ritchie's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 594
- Reproductive Medicine 129
- Biomaterials 110
- Toxicology 39
- Aging 11
Countries citing papers authored by Alison Ritchie
This map shows the geographic impact of Alison Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Ritchie more than expected).
Fields of papers citing papers by Alison Ritchie
This network shows the impact of papers produced by Alison Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Ritchie. The network helps show where Alison Ritchie may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison Ritchie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 550 | |
| 2 | Does age matter? The impact of rodent age on study outcomes Hit paper breakdown → | 2016 | 284 |
| 3 | Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. | 1992 | 78 |
| 4 | 2001 | 63 | |
| 5 | 2020 | 59 | |
| 6 | 1996 | 57 | |
| 7 | 1994 | 55 | |
| 8 | 2021 | 48 | |
| 9 | 1997 | 45 | |
| 10 | 1993 | 39 | |
| 11 | 2014 | 38 | |
| 12 | Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen. | 1998 | 35 |
| 13 | 1998 | 30 | |
| 14 | 2001 | 28 | |
| 15 | 2016 | 26 | |
| 16 | 2020 | 26 | |
| 17 | 2013 | 25 | |
| 18 | 1998 | 24 | |
| 19 | 1995 | 23 | |
| 20 | 2020 | 23 |
About Alison Ritchie
Alison Ritchie is a scholar working on Reproductive Medicine, Biomaterials, Oncology, Molecular Medicine and Toxicology, having authored 44 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Estrogen and related hormone effects (5 papers), Cancer Cells and Metastasis (4 papers), Hydrogels: synthesis, properties, applications (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Neuropeptides and Animal Physiology (3 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (594 citations), Reproductive Medicine (129 citations), Biomaterials (110 citations), Toxicology (39 citations) and Aging (11 citations). Alison Ritchie has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Morwenna Muir, Jeff Cummings, Duncan Ian Jodrell, Rhona E. Aird, Peter John Sadler, Simon P. Langdon, William R. Miller, John F. Smyth, Peter Mullen and Mark S. Yeoman. Their work appears in journals such as European Journal of Cancer, Biomaterials Science, British Journal of Cancer, Annals of Oncology and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.